GCAL® - Plasma and serum calprotectin in routine use

Clinical value: Plasma and serum calprotectin

Calprotectin in blood shows significant diagnostic value in various infectious and inflammatory conditions, and the biomarker is gaining more and more interest. GCAL^® - Gentian's plasma and serum calprotectin assay is today in routine use at various hospitals and clinical chemistry laboratories across Europe where the assay is used in the fields of:

• Intensive care
• Emergency medicine
• Neurology
• Paediatrics
• Hepato-gastroenterology
• Rheumatology
• Dermatology
• COVID-19 prognosis
  
  

Routine use of GCAL^® - Plasma and serum calprotectin

Two institutions using GCAL^® in routine at their institutions are  Labor Berlin – Charité Vivantes GmbH in Germany and the Assistance Publique-Hôpitaux de Paris (APHP Centre) in France.

Labor Berlin experienced an increasing demand for plasma and serum calprotectin testing, and therefore wanted to implement an automated solution for plasma and serum calprotectin. APHP was searching for additional biomarkers to complement routine biomarkers like CRP, IL-6 during the 1^st COVID-19 wave, looking for a biomarker that would better stratify severity and prognosis¹. 

The answer to demand for an automated plasma and serum calprotectin

Labor Berlin – Charité Vivantes GmbH has a broad spectrum of use of calprotectin at their associated hospitals. The test is open to order for all their clinical departments, and requests span from multiple clinical areas, including neurology, paediatrics, rheumatology, dermatology and ICU.

From part of clinical studies to routine inflammation marker

At the Assistance Publique-Hôpitaux de Paris (APHP Centre) the interest in calprotectin came with a need for new biomarkers during the 1^st COVID-19 wave. After seeing the strong association of calprotectin with COVID-19 severity and prognosis, the biomarker is now also perceived as a new informative biomarker of residual inflammation in autoimmune diseases and a valuable biomarker in clinical practice.

Webinar: Calprotectin, a new routine inflammation biomarker, APHP Centre

This webinar is especially noteworthy for laboratory professionals and clinicians who are already familiar with plasma and serum calprotectin, and that are curious to learn more from the experience of routine customer of the Gentian Calprotectin GCAL^®. At APHP Centre the biomarker is perceived as an  informative biomarker of residual inflammation in autoimmune diseases and a valuable biomarker in clinical practice. 

IVDR certified

GCAL^® is certified by TüV SÜD as complying with the European In-Vitro Diagnostic Regulation (IVDR), EU 2017/746.

Contact us for further information

Explore GCAL^® in your laboratory - fill out the form or send an email to marketing@gentian.com for more information about the product and prices.

References:

1. www.gentian.com/news/webinar-calprotectin-routine-inflammation-biomarker